Medanta, The Medicity, India
19
6
7
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 19 trials
100.0%
+13.4% vs industry average
11%
2 trials in Phase 3/4
0%
0 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (19)
EUS-Guided Coil and Glue vs Glue Injection for Bleeding Gastric Varices in Cirrhosis
Role: lead
Composite Index for Outcome Burden in Acute Cholangitis
Role: collaborator
To Assess the Prevalence, Management Practices, and Clinical Outcomes Associated With Hyperglycemia Among Hospitalized Patients, With a Particular Focus on the Interplay Between Metabolic Biomarkers, Nutritional Status, and Body Composition
Role: lead
Effect of Dapagliflozin vs Sitagliptin on Liver Fat Accumulation and Body Composition in Patients With Diabetes Mellitus and Liver Transplantation
Role: lead
Combining Gene Variants to Improve Risk Prediction for Metabolic (Dysfunction)- Associated Fatty Liver Disease and Its Progression to Cirrhosis in Indian Individuals With Type 2 Diabetes
Role: lead
Effect of Bempedoic Acid on Liver Fat in Individuals With Nonalcoholic Fatty Liver Disease and Type 2 Diabetes
Role: lead
Efficay and Safety of Empagliflozin Versus Sitagliptin for the In-patient Management of Hyperglycemia
Role: lead
Effect of Oral Semaglutide on Liver Fat and Body Composition in Liver Transplant Recipients With Diabetes Mellitus
Role: lead
Randomized Trial of EUS-guided Gastrojejunostomy and Surgical Gastrojejunostomy in Gastric Outlet Obstruction
Role: collaborator
Degludec Glargine U300 Hospital Study
Role: lead
Effect of Empagliflozin vs Linagliptin on Glycemic Outcomes,Renal Outcomes & Body Composition in Renal Transplant Recipients With Diabetes Mellitus
Role: lead
Empagliflozin Versus Linagliptin in Renal Ransplant Recipients With Diabetes Mellitus
Role: lead
Efficacy and Safety of Dapagliflozin for the Hospital Management of Patients With Type 2 Diabetes
Role: lead
Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates
Role: collaborator
Asian Diabetes Outcomes Prevention Trial
Role: collaborator
Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
Role: lead
Effect of Empagliflozin on Liver Fat Content in Patients With Type 2 Diabetes
Role: lead
Pneumatic Compression for Preventing Venous Thromboembolism
Role: collaborator
An Open Label,Observational, Real Time Data Capturing of Usage & Outcome of Coseal
Role: lead
All 19 trials loaded